Viennese biomarker study casts light on breast cancer risk
January 24, 2020 -- Austrian investigators have used PET and MRI to find out that patients with a malignant tumor in one breast have lower levels of certain biomarkers in the contralateral, healthy breast. They examined 141 women who had imaging abnormalities in one breast and a tumor-free contralateral breast.  Discuss
PET strengthens case for cause of schizophrenia
January 17, 2020 -- By combining PET imaging with a radiotracer that binds to a specific protein, U.K. researchers may have validated the belief that dysfunctional neuronal connections in the brain are the underlying cause of schizophrenia, according to a study published on 14 January in Nature Communications.  Discuss
Report: Fujifilm makes pitch for Curium Pharma
January 16, 2020 -- In what would be its latest deal in an ongoing acquisition spree in healthcare, Fujifilm has made an offer to buy French radiopharmaceutical developer Curium Pharma in a transaction that could be valued as high as 2.7 billion euros, according to a 14 January report from Bloomberg.  Discuss
Dutch refine use of PET to predict cancer therapy outcome
December 20, 2019 -- Researchers from the Netherlands are edging closer to proving the value of zirconium-89 immuno-PET as a noninvasive approach to predicting the effectiveness of therapy for cancerous tumors. Their findings have appeared in the December edition of the Journal of Nuclear Medicine.  Discuss
AI-assisted FDG-PET/CT advances lung nodule detection
December 16, 2019 -- Swiss investigators have developed an artificial intelligence (AI) algorithm that could become a valuable tool for detecting small, FDG-avid pulmonary nodules on oncologic PET/CT scans, according to a study published online on 10 December in European Radiology.  Discuss
Novel therapy brings hope in neuroendocrine tumors
December 16, 2019 -- Award-winning researchers from a top London facility have demonstrated how lutetium-177 peptide receptor radionuclide therapy is showing significant promise in the treatment of patients with inoperable or metastasized neuroendocrine tumors.  Discuss
PET/MRI wins support in breast lesion comparisons
December 16, 2019 -- Researchers from the University of Düsseldorf in Germany have found that the combination of PET with MRI was statistically superior to MRI alone for normal detection and staging of breast cancer, as well as in the detection of distant metastases (M staging). They revealed their findings at RSNA 2019.  Discuss
German team shows value of FDG-PET/MRI in breast cancer
December 13, 2019 -- A new study from Düsseldorf, Germany, has found that FDG-PET/MRI shows promise for accurate staging of breast cancer, but the modality still isn't as accurate as sentinel lymph node biopsy. The researchers presented their results at RSNA 2019.  Discuss
Is it safe to undergo FDG-PET/CT after cardiac surgery?
December 5, 2019 -- Determining when it's safe for patients to undergo FDG-PET/CT after aortic prosthetic heart valve implantation is a controversial topic. A Dutch study presented on Tuesday at RSNA 2019 found that such a scan within the first 12 months is viable.  Discuss
FDG-PET/CT has limits in esophageal cancer follow-up
November 7, 2019 -- FDG-PET/CT might be considered a double-edged sword when it comes to esophageal cancer. The modality fell short of identifying some higher tumor regression grades, but it detected interval metastases during post-treatment surveillance in a study published in the November issue of the Journal of Nuclear Medicine.  Discuss